A Danish study has highlighted the risk of using certain hormonal contraceptives, especially hormone-based combination pills, ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

After adjusting for factors such as age, education, high blood pressure and diabetes, researchers linked the estrogen-progestin pill — known colloquially as the birth control pill — to twice the risk ...

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

Data suggest a dose-related association between progestin-only products and arterial thrombotic risk. Various hormonal contraceptives were linked to incident cardiovascular disease in an analysis of ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

Proper body care, learning about specific triggers, and taking a more holistic approach to heart health can help ... People with AFib have many treatment options, including medications and medical ...

Sheets of lab-grown muscle are being tested as a radical new treatment for heart attacks and heart failure. Promising results from two of the first patients to get the treatment suggest that the ...